Shake Shack (SHAK) FY Conference June 11, 2025 02:15 PM ET Speaker0 Hi, everyone. Thanks for participating in Oppenheimer's twenty fifth Annual Consumer Conference. I'm Mike Tamas, and I cover Shake Shack here at Oppenheimer. Know, Shake Shack's been one of our top picks in 2025, and we remain excited about management's new strategies to stimulate same store sales, enhance margins, and accelerate unit growth. We're gonna dig into all those topics and much more with Katie Fogarty, Shake Shack's CFO. She join ...

Core Viewpoint - Red Light Holland Corp. has successfully partnered with Irvine Labs, which has received a Controlled Substances Import Permit for psilocybin raw materials, enabling the shipment of 3 kg of psilocybin truffles from the Netherlands to the United States for research and development purposes [2][3][6]. Company Overview - Red Light Holland is an Ontario-based corporation focused on the production, growth, and sale of functional mushrooms and psilocybin truffles in compliance with legal regulations in North America and Europe [2][10]. - Irvine Labs, established in 1997, specializes in medical research and development, particularly in natural medicines, and is licensed for drug manufacturing by the California Department of Public Health [4][9]. Regulatory Milestones - Irvine Labs has secured the Controlled Substances Import Permit, allowing the import of psilocybin raw materials, which is a significant regulatory achievement for the partnership [3][8]. - The import permit follows the 2025 psilocybin DEA quotas announced in April, indicating a structured regulatory framework for psilocybin research [2][6]. Research and Development Focus - The partnership aims to develop extended shelf-life microdosing capsules from psilocybin truffles, utilizing proprietary preservation technology to maintain product integrity [5][8]. - Both companies are committed to standardizing naturally occurring psilocybin and ensuring product stability and quality throughout the supply chain [5][8]. Market Potential - The collaboration aims to create a commercialized and standardized psilocybin product that can be legally exported to emerging markets and utilized in clinical trials and government-funded pilot programs in the United States [8][6].

COMPANY ANNOUNCEMENT No. 207/2025 Tvis, 21 May 2025 Interim report Q1 2025 (January 1 - March 31) (All figures in brackets refer to the corresponding period in 2024) Organic sales growth driven by a recovering B2C market. CEO Torben Paulin:“Sales in the first quarter developed in line with our expectations, with a decline in B2B project sales offset by a robust increase in B2C sales. Total sales for the quarter rose by 5% year-on-year to DKK 308 million, with an organic growth of 4%. Order intake showed p ...

募资失利。 作者 I 王露 报道 I 投资界PEdaily 消息传来，金·卡戴珊（Kim Ka r da s h i a n）不再执掌由她创立的风投机构SKKY Pa rt n e rs，已正式辞任执行合伙人。 作为全球流量女王，卡戴珊的名字，许多人一定不会陌生。20 22年，她与凯雷集团前合 伙人J a y Sammo ns共同创立了这家风投，专注消费领域投资。 没想到，募资失败令卡戴珊风投事业夭折——过去近两年，SKKY旗下基金募集只到原定 规模的十分之一。这位全球网红一姐也没能扛住"募资难"。 这也许是这位全球红网一姐人生中为数不多的失败经历。 回想2 5岁时，卡戴珊拍了人生中第一部电影，两年后凭借经纪人母亲一手推出的真人秀 《与卡戴珊姐妹同行》爆红。这位拥有4. 3亿粉丝的超级网红偏爱创业，短短十多年间她 的商业版图扩展至影视、服装、游戏、美妆等领域，坐拥18亿美元财富。 卡戴珊旗下最成功的创业案例莫过于内衣品牌Skims，凭借着其强大的个人IP影响力，以 及戳中女性身材焦虑的痛点，上市开售仅两分钟就在全美卖出了近1 0万件。2 02 3年公司 估值一跃达到4 0亿美元（接近300亿人民币），一度传出 ...